Koizumi indicated that through 2016, the National Science Foundation, Department of Energy and National Institute of Standards and Technology will see their annual budgets doubled. The premise behind this is to foster basic science. NIH funding will remain essentially flat at about $30B annually, where it has been since 2003. Koizumi indicated that the new Director of NIH, Francis Collins has defined specific investment areas to be pursued in 2010 and beyond. They include:
- Genomics and high throughput technologies for disease research
- Translation of basic research into treatments, especially for diseases with limited market potential
- Science for health care reform
- Global health initiatives
- Reinvigorating health care
Do you agree with where the R&D investments are being made?
By, BioTek Instruments